FAIRFIELD, Conn., May 24, 2010 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (NYSE Amex:CTT) today announced the issuance of an abstract of a study which has shown the successful treatment of Chronic Cancer Pain (CCP) using CTT’s Calmare® Pain Therapy Treatment for patients with advanced stages of cancer. The abstract cites results of the study, which will be published in the proceedings of the American Society of Clinical Oncology (ASCO) Annual Meeting to be held June 4-8, 2010. Also at this meeting, the results of a previously announced study showing successful treatment of patients suffering from pain associated with chemotherapy-induced peripheral neuropathy (CIPN) using Calmare pain therapy will be presented.
